Redfield, Margaret M <br/><br/>
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.  [electronic resource] 

 -  JAMA  Mar 2013 
 - 1268-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1538-3598 
<br/><br/><label>Standard No.: </label>10.1001/jama.2013.2024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Pressure<br/>Double-Blind Method<br/>Exercise Tolerance<br/>Female<br/>Health Status<br/>Heart Failure--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Outpatients<br/>Oxygen Consumption<br/>Phosphodiesterase 5 Inhibitors--therapeutic use<br/>Piperazines--therapeutic use<br/>Purines--therapeutic use<br/>Sildenafil Citrate<br/>Stroke Volume<br/>Sulfones--therapeutic use<br/>Treatment Outcome<br/>Walking